圣诺生物
(688117)
| 流通市值：65.17亿 | | | 总市值：65.17亿 |
| 流通股本：1.57亿 | | | 总股本：1.57亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 227,749,960.65 | 281,625,596.17 | 175,233,865.96 | 218,705,136.59 |
| 交易性金融资产 | 67,000,000 | 10,670,000 | 10,025,000 | 20,157,000 |
| 应收票据及应收账款 | 143,571,253.94 | 85,772,147.2 | 154,166,280.03 | 102,667,258.27 |
| 其中：应收票据 | - | - | 960,330.42 | 914,693.39 |
| 应收账款 | 143,571,253.94 | 85,772,147.2 | 153,205,949.61 | 101,752,564.88 |
| 应收款项融资 | 405,943 | 1,269,488 | 316,840 | 495,891.84 |
| 预付款项 | 14,635,620.92 | 12,262,166.28 | 13,691,652.4 | 12,342,630.49 |
| 其他应收款合计 | 6,667,929.2 | 5,425,476.93 | 5,538,252.35 | 7,972,549.71 |
| 存货 | 330,248,036.29 | 313,344,275.18 | 293,371,482.07 | 304,753,127.04 |
| 合同资产 | 34,921,254.72 | 28,889,866.47 | 19,769,241.01 | 22,034,841.77 |
| 其他流动资产 | 40,592,255.76 | 44,850,802.96 | 35,981,777.83 | 29,078,327.46 |
| 流动资产合计 | 865,792,254.48 | 784,109,819.19 | 708,094,391.65 | 718,206,763.17 |
| 非流动资产: | | | | |
| 长期股权投资 | 21,293,874.28 | 21,744,272.86 | 21,483,316.51 | 21,189,315.43 |
| 其他权益工具投资 | 89,405,000 | 49,405,000 | 45,955,932.96 | 58,405,000 |
| 其他非流动金融资产 | 40,447,648 | 35,947,648 | 35,947,648 | 31,447,648 |
| 投资性房地产 | 2,771,346.92 | 2,857,243.52 | 1,728,790.15 | 1,783,159.24 |
| 固定资产 | 549,329,969.85 | 534,299,011.56 | 376,468,978.46 | 377,616,992.1 |
| 在建工程 | 212,346,338.68 | 231,004,425.73 | 371,232,256.34 | 348,971,162.49 |
| 使用权资产 | - | 363,538.49 | 604,533.86 | 845,529.23 |
| 无形资产 | 80,692,946.75 | 55,536,571.2 | 55,972,456.1 | 40,195,857.72 |
| 开发支出 | 15,072,383.44 | 13,802,042.64 | 12,996,001.75 | 12,787,729.61 |
| 长期待摊费用 | 2,899,829.37 | 2,629,243.75 | 1,145,817.19 | 1,310,699.47 |
| 递延所得税资产 | 12,576,517.09 | 13,362,244.95 | 10,273,510 | 9,484,918.36 |
| 其他非流动资产 | 16,518,809.33 | 10,934,305.47 | 22,989,809.84 | 25,655,746.14 |
| 非流动资产合计 | 1,043,354,663.71 | 971,885,548.17 | 956,799,051.16 | 929,693,757.79 |
| 资产总计 | 1,909,146,918.19 | 1,755,995,367.36 | 1,664,893,442.81 | 1,647,900,520.96 |
| 流动负债: | | | | |
| 短期借款 | 218,153,616.25 | 208,676,238.88 | 192,642,050 | 200,157,720.37 |
| 应付票据及应付账款 | 101,086,484.53 | 107,416,908.98 | 115,770,122.06 | 130,417,700.86 |
| 其中：应付票据 | 26,995,248 | 30,092,968.15 | 40,944,172.15 | 51,652,578.6 |
| 应付账款 | 74,091,236.53 | 77,323,940.83 | 74,825,949.91 | 78,765,122.26 |
| 合同负债 | 19,592,142.14 | 14,831,595.3 | 26,481,093 | 26,888,436.26 |
| 应付职工薪酬 | 17,088,061.52 | 14,310,766.87 | 11,179,365.59 | 20,142,205.27 |
| 应交税费 | 10,403,459.17 | 8,531,867.71 | 10,392,306.38 | 3,360,909.48 |
| 其他应付款合计 | 58,485,589.67 | 61,704,231.1 | 57,773,011.76 | 61,688,240 |
| 一年内到期的非流动负债 | 169,701,833.34 | 183,813,293.45 | 167,085,632.62 | 100,230,728.3 |
| 其他流动负债 | - | - | 785,105.29 | 574,010.99 |
| 流动负债合计 | 594,511,186.62 | 599,284,902.29 | 582,108,686.7 | 543,459,951.53 |
| 非流动负债: | | | | |
| 长期借款 | 180,245,723.98 | 142,233,509.93 | 96,939,801.51 | 182,030,162.93 |
| 长期应付款 | 81,203,029.83 | - | - | - |
| 递延收益 | 21,276,718.8 | 21,387,666.94 | 19,598,436.36 | 4,088,005.79 |
| 非流动负债合计 | 282,725,472.61 | 163,621,176.87 | 116,538,237.87 | 186,118,168.72 |
| 负债合计 | 877,236,659.23 | 762,906,079.16 | 698,646,924.57 | 729,578,120.25 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 157,385,978 | 157,385,978 | 112,418,556 | 112,418,556 |
| 资本公积 | 346,919,260.43 | 346,151,764.38 | 390,374,812.81 | 389,591,430.29 |
| 盈余公积 | 18,702,580.42 | 18,702,580.42 | 18,702,580.42 | 18,702,580.42 |
| 未分配利润 | 508,902,440.11 | 470,848,965.4 | 444,750,569.01 | 397,630,868.79 |
| 归属于母公司股东权益合计 | 1,031,910,258.96 | 993,089,288.2 | 966,246,518.24 | 918,343,435.5 |
| 少数股东权益 | - | - | - | -21,034.79 |
| 股东权益合计 | 1,031,910,258.96 | 993,089,288.2 | 966,246,518.24 | 918,322,400.71 |
| 负债和股东权益合计 | 1,909,146,918.19 | 1,755,995,367.36 | 1,664,893,442.81 | 1,647,900,520.96 |
| 公告日期 | 2025-10-28 | 2025-08-15 | 2025-04-25 | 2025-04-25 |
| 审计意见(境内) | | | | 标准无保留意见 |